Find valuable ACTEMRA® (tocilizumab) information, including an ACR= American College of Rheumatology; DMARD=disease-modifying antirheumatic drug. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Actimmune (tocilizumab). 27 Oct PRODUCT MONOGRAPH. Pr. ACTEMRA. ® tocilizumab. 20 mg/mL Concentrate Solution for Infusion. mg/ mL Solution for Injection.
|Published (Last):||6 April 2018|
|PDF File Size:||14.89 Mb|
|ePub File Size:||17.90 Mb|
|Price:||Free* [*Free Regsitration Required]|
Our patient support program is designed to help you better manage life actemra package insert rheumatoid arthritis. Neutrophils are white blood cells that help the body fight infection low platelet count.
Your healthcare provider should do blood tests to check your cholesterol levels 4 to 8 weeks after you start receiving ACTEMRA, and then every 6 months after actemra package insert You should not receive ACTEMRA if your neutrophil and platelet counts are too low or your liver function test levels are too high.
Thanks for sharing this page. The following packaging configurations are actemra package insert The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Protect the vials from light by storage in the original package until imsert of use.
Rheumatoid Arthritis Treatment | ACTEMRA® (tocilizumab)
Actemra package insert most common events occurring during infusion were headache, nausea and hypotension, and occurring within 24 hours of infusion were dizziness and hypotension. Tell your healthcare provider right away if you see any signs of these symptoms:.
Shortness of breath or trouble breathing Swelling of lips, tongue, or face Actemra package insert pain Feeling dizzy or faint Moderate or severe abdominal pain or vomiting. Contact immediately, as well as your healthcare provider or nurse, if you experience any of these actemra package insert.
Click “OK” if you are a healthcare professional. In the 6-month control period, in SC-I, the frequency of injection-site reactions ineert Bacterial, viral and other infections due to opportunistic pathogens. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.
FDA Internet Application Site (Accessdata) Error
Infection signs, with or without a fever, include: Most common side effects Tell your healthcare provider if actemra package insert have these or any other side effect that onsert you or does not go away: These actemra package insert reactions were mild to moderate in severity.
This happens most often in people who also take nonsteroidal anti-inflammatory drugs NSAIDscorticosteroids, or methotrexate. When used in combination with DMARDs or as monotherapy the recommended starting dose is 4 mg actemra package insert kg followed by an increase to 8 packagw per kg based on clinical response. The risks and benefits of treatment with ACTEMRA should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection.
You may also call Genentech at Demyelinating Disorders The impact of treatment with ACTEMRA on demyelinating disorders is not known, but multiple sclerosis and chronic inflammatory demyelinating polyneuropathy lackage reported rarely in clinical studies. Parenteral packae products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Systemic Juvenile Idiopathic Arthritis Patients less than 30 kg: The rate of serious infections was 9.
Prescribers should exercise caution in considering the use of ACTEMRA in patients with preexisting or recent-onset demyelinating disorders.
Your use actemra package insert third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Gastrointestinal GI nisert — use with caution in patients who may be at increased risk. There was no clear relationship between decreases actemra package insert neutrophils below 1 x 10 9 per L and the occurrence of serious infections.
Actemra package insert, for intravenous infusion Initial U. The risks and benefits of treatment with ACTEMRA should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection.
IL-6 is a pleiotropic pro-inflammatory cytokine produced by a variety of cell types including T- and B-cells, lymphocytes, monocytes and fibroblasts. Increased blood pressure also called hypertension.
Lab Values – A thru Z. Acremra evaluate patients presenting with new-onset abdominal symptoms for early identification of GI perforation. The most common serious adverse reactions were serious infections.